Ragon Institute of Mass General, MIT, and Harvard
Wilfredo Garcia Beltran, MD, PhD, is a dedicated clinician-scientist currently serving as a Fellow at the Ragon Institute of MGH, MIT, and Harvard since July 2021, while also fulfilling the role of Clinical Pathology Resident at Massachusetts General Hospital since July 2018. Prior experience includes a Transfusion Medicine Fellowship at Brigham and Women's Hospital from July 2020 to June 2021. Educational credentials encompass a Doctor of Medicine degree from Harvard Medical School, awarded in 2018; a Doctor of Philosophy in Immunology from Harvard Kenneth C. Griffin Graduate School of Arts and Sciences, obtained in 2016; and a Bachelor of Science in Chemistry from the University of Puerto Rico, Río Piedras, earned in 2010.
This person is not in the org chart
Ragon Institute of Mass General, MIT, and Harvard
1 followers
The Ragon Institute was established in 2009 with a dual mission: to contribute to the accelerated discovery of an HIV/AIDS vaccine and subsequently establish itself as a world leader in the collaborative study of immunology. Founded with a commitment of $100 million from Phillip T. (Terry) and Susan M. Ragon, and with an additional $200 million gift to endow the Institute announced on April 26, 2019, the Institute is structured and positioned to significantly contribute to a global effort to successfully develop an HIV/AIDS vaccine by: • Creating non-traditional partnerships among experts with different but complementary backgrounds; • Providing a means for rapidly funding promising studies; • Integrating key facets of vaccine development efforts that have tended to follow separate tracks; • Providing a substantial pool of accessible, flexible funding that lowers the threshold for scientists to pursue risky, unconventional avenues of study that are unlikely to attract funding from traditional sources. Such funding encourages innovation, compresses the time it takes to conduct bench-to-bedside research and attracts new minds to the field. The Ragon Institute creates a singular opportunity and environment to engage scientists, engineers and clinicians in challenging research for which there is no greater benefit – saving lives and curing the ill.